Radio-sensitization of gliomas by intracellular generation of 5-fluorouracil potentiates prodrug activator gene therapy with a retroviral replicating vector

A tumor-selective non-lytic retroviral replicating vector (RRV), Toca 511, and an extended-release formulation of 5-fluorocytosine (5-FC), Toca FC, are currently being evaluated in clinical trials in patients with recurrent high-grade glioma (NCT01156584, NCT01470794, NCT01985256). Tumor-selective p...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Masamichi, Valdes, Gilmer, Hiraoka, Kei, Inagaki, Akihito, Kamijima, Shuichi, Micewicz, Ewa, Gruber, Harry E., Robbins, Joan M., Jolly, Douglas J., McBride, William H., Iwamoto, Keisuke S., Kasahara, Noriyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246057/
https://www.ncbi.nlm.nih.gov/pubmed/25301172
http://dx.doi.org/10.1038/cgt.2014.38

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246057/
https://www.ncbi.nlm.nih.gov/pubmed/25301172
http://dx.doi.org/10.1038/cgt.2014.38

Ejemplares similares